研究・業績目録｜業績｜北海道大学薬学研究院／生体分子機能学研究室

研究・業績目録

Protein kinase Cβ is involved in cigarette smoke gas phase-induced ferroptosis in J774 macrophages.
Higashi T, Handa H, Mai Y, Maenaka K, Tadokoro T.
J Pharmacol Sci. 2023 Sep;153(1):22-25. doi: 10.1016/j.jphs.2023.06.001. Epub 2023 Jun 21.
PMID: 37524450

Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariants.
Moriyama S, Anraku Y, Taminishi S, Adachi Y, Kuroda D, Kita S, Higuchi Y, Kirita Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y.
Nat Commun. 2023 Jul 14;14(1):4198. doi: 10.1038/s41467-023-39890-8.
PMID: 37452031

Structural basis for plastic glycolipid recognition of the C-type lectin Mincle.
Furukawa A, Shuchi Y, Wang J, Guillen-Poza PA, Ishizuka S, Kagoshima M, Ikeno R, Kumeta H, Yamasaki S, Matsumaru T, Saitoh T, Maenaka K.
Structure. 2023 Jun 11:S0969-2126(23)00194-6. doi: 10.1016/j.str.2023.05.018. Online ahead of print.
PMID: 37348496

Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants.
Tamura T, Ito J, Uriu K, Zahradnik J, Kida I, Anraku Y, Nasser H, Shofa M, Oda Y, Lytras S, Nao N, Itakura Y, Deguchi S, Suzuki R, Wang L, Begum MM, Kita S, Yajima H, Sasaki J, Sasaki-Tabata K, Shimizu R, Tsuda M, Kosugi Y, Fujita S, Pan L, Sauter D, Yoshimatsu K, Suzuki S, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Yamamoto Y, Nagamoto T, Schreiber G, Maenaka K; Genotype to Phenotype Japan (G2P-Japan) Consortium; Hashiguchi T, Ikeda T, Fukuhara T, Saito A, Tanaka S, Matsuno K, Takayama K, Sato K.
Nat Commun. 2023 May 16;14(1):2800. doi: 10.1038/s41467-023-38435-3.
PMID: 37193706

Ready-to-Use-Type Lyophilized Lipid Nanoparticle Formulation for the Postencapsulation of Messenger RNA.
Tanaka H, Hagiwara S, Shirane D, Yamakawa T, Sato Y, Matsumoto C, Ishizaki K, Hishinuma M, Chida K, Sasaki K, Yonemochi E, Ueda K, Higashi K, Moribe K, Tadokoro T, Maenaka K,, Taneichi S, Nakai Y, Tange K, Sakurai Y, Akita
H.ACS Nano. 2023 Feb 14;17(3):2588-2601. doi: 10.1021/acsnano.2c10501. Epub 2023 Jan 31.
PMID: 36719091

2-thiouridine is a broad-spectrum antiviral nucleoside analogue against positive-strand RNA viruses.
Uemura K, Nobori H, Sato A, Toba S, Kusakabe S, Sasaki M, Tabata K, Matsuno K, Maeda N, Ito S, Tanaka M, Anraku Y, Kita S, Ishii M, Kanamitsu K, Orba Y, Matsuura Y, Hall WW, Sawa H, Kida H, Matsuda A, Maenaka K
Proc Natl Acad Sci U S A. 2023 Oct 17;120(42):e2304139120. doi: 10.1073/pnas.2304139120. Epub 2023 Oct 13.
PMID: 37831739

Beneficial effects of a new neuroprotective compound in neuronal cells and MPTP- administered mouse model of Parkinson's disease.
Kato I, Ogawa Y, Yakushiji F, Ogura J, Kobayashi M, Shindo N, Ichikawa S, Maenaka K, Sakaitani M.Chem Commun (Camb). 2023 Oct 12;59(82):12306-12309. doi: 10.1039/d3cc03069e.
PMID: 37753573

An Electron-Deficient CpE Iridium(III) Catalyst: Synthesis, Characterization, and Application to Ether-Directed C-H Amidation.
Tomita E, Kojima M, Nagashima Y, Tanaka K, Sugiyama H, Segawa Y, Furukawa A, Maenaka K, Maeda S, Yoshino T, Matsunaga S.Angew
Chem Int Ed Engl. 2023 May 15;62(21):e202301259. doi: 10.1002/anie.202301259. Epub 2023 Apr 14.
PMID: 36918357

Corrigendum: Intraocular human cytomegaloviruses of ocular diseases are distinct from those of viremia and are capable of escaping from innate and adaptive immunity by exploiting HLA-E-mediated peripheral and central tolerance.
Shirane M, Yawata N, Motooka D, Shibata K, Khor SS, Omae Y, Kaburaki T, Yanai R, Mashimo H, Yamana S, Ito T, Hayashida A, Mori Y, Numata A, Murakami Y, Fujiwara K, Ohguro N, Hosogai M, Akiyama M, Hasegawa E, Paley M, Takeda A, Maenaka K, Akashi K, Yokoyama WM, Tokunaga K, Yawata M, Sonoda KH.Front Immunol. 2023 Jan 5;13:1124440. doi: 10.3389/fimmu.2022.1124440. eCollection 2022..
PMID: 36685570

総説、共著など